FDA Inspection 1274433 — Seattle Sperm Bank

Seattle Sperm Bank — FEI 3028170589

The FDA completed an inspection of Seattle Sperm Bank on June 12, 2025 in Denver, CO. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 12, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Denver, CO (United States)

Citations

IDCFRDescription
1223721 CFR 1271.55(a)(3)Summary--records used to make determination
1227221 CFR 1271.65(b)(2)Labeled re: biohazard, risks, test results